For breast cancer, despite the association of RIF1 with various pro-oncogenic processes, we observed no significant change in RIF1 gene expression between normal and cancer tissue (Figure 1C) and no association of RIF1 mRNA expression level with survival outcomes (Figure 1D). This evidence concerns the gene RIF1 and breast cancer.